Vitiligo as durvalumab's immune-related adverse event in lung cancer

  1. Rogado, J.
  2. Buendía-Castaño, D.
  3. Alonso-García, S.R.
Revue:
Medicina Clinica

ISSN: 1578-8989 0025-7753

Année de publication: 2022

Volumen: 158

Número: 7

Pages: 341-342

Type: Article

DOI: 10.1016/J.MEDCLI.2021.07.024 GOOGLE SCHOLAR